Alaunos Therapeutics Inc (TCRT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.86M
Last updated: Nov 17, 2026 at 11:05 AM ET
Alaunos Therapeutics Inc (TCRT) Competitors
The companies most similar to Alaunos Therapeutics are Bioatla (BCAB), Lantern Pharma (LTRN) and Liminatus Pharma, Inc. Class A Common Stock (LIMN). By market cap, Alaunos Therapeutics ranks 4th of the 13 companies on this page; In8bio (INAB) is the largest at $8.86M.
Peer Comparison
TCRT's revenue growth of -25.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics (TCRT) | $6.86M | N/A | N/A | 0.0% | N/A | -25.0% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| Lantern Pharma Inc (LTRN) | $6.47M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.02M | N/A | N/A | 0.0% | -247.2% | 0.0% | 0.00% |
| Aprea Therapeutics Inc (APRE) | $5.91M | N/A | N/A | 0.0% | N/A | -98.4% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| Theriva Biologics Inc. (TOVX) | $6.61M | N/A | 21.5x | 0.0% | -52.3% | 0.0% | 0.00% |
| Tempest Therapeutics Inc (TPST) | $7.64M | N/A | N/A | 0.0% | -783.6% | 0.0% | 0.00% |
| In8bio Inc (INAB) | $8.86M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Soligenix Inc. (SNGX) | $7.50M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Processa Pharmaceuticals Inc (PCSA) | $5.20M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Galmed Pharmaceuticals Ltd (GLMD) | $4.95M | N/A | N/A | 0.0% | N/A | 0.0% | N/A |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | $3.93M | N/A | 4.0x | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $5.56M | N/A | 12.7x | 0.0% | -189.4% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Alaunos Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| Lantern Pharma Inc (LTRN) | Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics... | LTRN competitors |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California. | LIMN competitors |
| Aprea Therapeutics Inc (APRE) | Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor... | APRE competitors |
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
| Theriva Biologics Inc. (TOVX) | Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. | TOVX competitors |
| Tempest Therapeutics Inc (TPST) | Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated... | TPST competitors |
| In8bio Inc (INAB) | IN8bio, Inc., a clinical-stage biotechnology company, is focused on developing new therapies for the treatment of cancers... | INAB competitors |
| Soligenix Inc. (SNGX) | Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. | SNGX competitors |
| Processa Pharmaceuticals Inc (PCSA) | Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients... | PCSA competitors |
| Galmed Pharmaceuticals Ltd (GLMD) | Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases. | |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment... |
Frequently Asked Questions About TCRT
Who are Alaunos Therapeutics' main competitors?
The companies most similar to Alaunos Therapeutics include Bioatla (BCAB), Lantern Pharma (LTRN), Liminatus Pharma, Inc. Class A Common Stock (LIMN), Aprea Therapeutics (APRE) and Imunon (IMNN), listed from the closest match.
Who is Alaunos Therapeutics' biggest competitor?
In8bio (INAB) is the largest of the similar companies at $8.86M; Bioatla (BCAB) is the closest match by business profile, size, sector and industry.
How does TCRT stock compare with its competitors?
TCRT's net margin is 0.0% against a peer median of 0.0%.
Which of Alaunos Therapeutics' competitors pays a higher dividend?
Alaunos Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Alaunos Therapeutics bigger than its competitors?
No. Alaunos Therapeutics is 4th by market cap among the 13 companies on this page; the largest is In8bio (INAB) at $8.86M.
TCRT pages: Overview, Earnings, Financials, Competitors